Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Senter

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Methods in Enzymology|January 3, 2012
Conjugation of anticancer drugs through endogenous monoclonal antibody cysteine residuesRobert P Lyon, David L Meyer, Jocelyn R Setter, et al.
Nature Reviews. Drug Discovery|June 12, 2023
Antibody-drug conjugates come of age in oncologyCharles Dumontet, Janice M Reichert, Peter D Senter, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Reductively activated disulfide prodrugs of paclitaxelVivekananda M Vrudhula, John F MacMaster, Zhengong Li, et al.
Molecular Pharmaceutics|April 19, 2005
Novel antitumor prodrugs designed for activation by matrix metalloproteinases-2 and -9Toni Kline, Michael Y Torgov, Brian A Mendelsohn, et al.
Bioconjugate Chemistry|May 19, 2005
Generation of an intensely potent anthracycline by a monoclonal antibody-beta-galactosidase conjugateMichael Y Torgov, Stephen C Alley, Charles G Cerveny, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Cephalosporin prodrugs of paclitaxel for immunologically specific activation by L-49-sFv-beta-lactamase fusion proteinVivekananda M Vrudhula, David E Kerr, Nathan O Siemers, et al.
Cancer Research|April 17, 2004
Efficient cancer therapy with a nanobody-based conjugateVirna Cortez-Retamozo, Natalija Backmann, Peter D Senter, et al.
Bioconjugate Chemistry|July 22, 2004
Secondary mAb--vcMMAE conjugates are highly sensitive reporters of antibody internalization via the lysosome pathwayKerry Klussman, Bruce J Mixan, Charles G Cerveny, et al.
Molecular Pharmaceutics|August 9, 2007
Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivativeKai Temming, Damon L Meyer, Roger Zabinski, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Minor groove binder antibody conjugates employing a water soluble beta-glucuronide linkerScott C Jeffrey, Minh T Nguyen, Ruth F Moser, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Methods in Enzymology|January 3, 2012
Conjugation of anticancer drugs through endogenous monoclonal antibody cysteine residuesRobert P Lyon, David L Meyer, Jocelyn R Setter, et al.
Nature Reviews. Drug Discovery|June 12, 2023
Antibody-drug conjugates come of age in oncologyCharles Dumontet, Janice M Reichert, Peter D Senter, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Reductively activated disulfide prodrugs of paclitaxelVivekananda M Vrudhula, John F MacMaster, Zhengong Li, et al.
Molecular Pharmaceutics|April 19, 2005
Novel antitumor prodrugs designed for activation by matrix metalloproteinases-2 and -9Toni Kline, Michael Y Torgov, Brian A Mendelsohn, et al.
Bioconjugate Chemistry|May 19, 2005
Generation of an intensely potent anthracycline by a monoclonal antibody-beta-galactosidase conjugateMichael Y Torgov, Stephen C Alley, Charles G Cerveny, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Cephalosporin prodrugs of paclitaxel for immunologically specific activation by L-49-sFv-beta-lactamase fusion proteinVivekananda M Vrudhula, David E Kerr, Nathan O Siemers, et al.
Cancer Research|April 17, 2004
Efficient cancer therapy with a nanobody-based conjugateVirna Cortez-Retamozo, Natalija Backmann, Peter D Senter, et al.
Bioconjugate Chemistry|July 22, 2004
Secondary mAb--vcMMAE conjugates are highly sensitive reporters of antibody internalization via the lysosome pathwayKerry Klussman, Bruce J Mixan, Charles G Cerveny, et al.
Molecular Pharmaceutics|August 9, 2007
Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivativeKai Temming, Damon L Meyer, Roger Zabinski, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Minor groove binder antibody conjugates employing a water soluble beta-glucuronide linkerScott C Jeffrey, Minh T Nguyen, Ruth F Moser, et al.
Pageof 9